The stories we live by, a life-review method for people of 55 years and over with depressive and anxiety symptoms.

Prevention of Depression and Anxiety in Later Life: a Randomized Controlled Trial for the Clinical and Economic Evaluation of a Life-review Intervention.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON22643

Enrollment

200

Registered

2009-06-12

Start date

2008-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Anxiety

Interventions

Intervention: The stories we live by integrates narrative therapy and life-review. The intervention is aimed at four to six people and consists of eight similarly structured two-hour sessions. The es

Eligibility

Inclusion criteria

Inclusion criteria: 1. An age of 55 years or over; 2. The presence of slight to moderate depressive and anxiety symptoms. The presence of these symptoms will be measured by a score of 10 and above on the Dutch version of the Center for Epidemiological Studies Depression Scale (CES-D) and a score of 3 and above on the Dutch version ofthe anxiety scale of the Hospital and Anxiety Scale (HADS-A).

Exclusion criteria

Exclusion criteria: 1. Diagnosed with full-blown depression or having a moderate to high suicide risk according the Dutch version of the Mini International Neuropsychiatric Interview (MINI); 2. Scoring below the inclusion criteria of depressive and anxiety symptoms, measured by a score of 9 and below on the CES-D and a score of 2 and below on the HADS-A; 2. Started taking anti-depressant medication or benzodiazepines recently (within the previous 2 months); 3. Currently receiving any psychological treatment; 4. Other serious psychopathology; then people are referred for psychological treatment.

Design outcomes

Primary

Measure	Time frame
Depressive symptoms, measured with the CES-D.	—

Secondary

Measure	Time frame
Secundary outcomes: 1. Current major depressive episode, measured with the MINI; 2. Anxiety symptoms, measured with the HADS-A; 3. Quality of life, measured with the EuroQol 5-D; 4. Positive mental health, measured with the MHC-SF. Moderarting outcomes: 1. Demographics (age, gender and education level); 2. Personality, measured with the NEO-FFI; 3. Past major depressive episodes, measured with the MINI; 4. Important life events; 5. Chronic diseases. Mediating outcomes: 1. Reminiscence functions, measured with the RFS; 2. Perceived control, measured with the Mastery scale; 3. Automatic positive thoughts, measured with the ATQ-P; 4. Meaning in life, measured with the MLQ-SF. Measures for the economic evaluation: 1. Resource use, measured with the TIC-P; 2. Production losses, measured with the PRODISQ.	—

Measure

Time frame

Secundary outcomes: 1. Current major depressive episode, measured with the MINI; 2. Anxiety symptoms, measured with the HADS-A; 3. Quality of life, measured with the EuroQol 5-D; 4. Positive mental health, measured with the MHC-SF. Moderarting outcomes: 1. Demographics (age, gender and education level); 2. Personality, measured with the NEO-FFI; 3. Past major depressive episodes, measured with the MINI; 4. Important life events; 5. Chronic diseases. Mediating outcomes: 1. Reminiscence functions, measured with the RFS; 2. Perceived control, measured with the Mastery scale; 3. Automatic positive thoughts, measured with the ATQ-P; 4. Meaning in life, measured with the MLQ-SF. Measures for the economic evaluation: 1. Resource use, measured with the TIC-P; 2. Production losses, measured with the PRODISQ.

—

Contacts

Public ContactJojanneke Korte

P.O. Box 217

j.korte@utwente.nl0651071144

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)